Citation Impact
Citing Papers
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Intracranial Nocardia recurrence during fluorinated quinolones therapy
2006
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
Increasing the Opportunity of Live Kidney Donation by Matching for Two- and Three-Way Exchanges
2006 StandoutNobel
Cyclosporin A Inhibits Flow-mediated Activation of Endothelial Nitric-oxide Synthase by Altering Cholesterol Content in Caveolae
2004
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data
2005
PLASMAPHERESIS AND INTRAVENOUS IMMUNE GLOBULIN PROVIDES EFFECTIVE RESCUE THERAPY FOR REFRACTORY HUMORAL REJECTION AND ALLOWS KIDNEYS TO BE SUCCESSFULLY TRANSPLANTED INTO CROSS-MATCH-POSITIVE RECIPIENTS
2000
Nocardiosis: Updated Clinical Review and Experience at a Tertiary Center
2010 Standout
Mycobacterial infection in a series of 1261 renal transplant recipients
2003
Pre-emptive Treatment for Cytomegalovirus Viremia to Prevent Cytomegalovirus Disease in Solid Organ Transplant Recipients
2006
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
2005
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Elevated calcium phosphate product after renal transplantation is a risk factor for graft failure
2007
Nocardiosis at the Turn of the Century
2009 Standout
Risk Factors, Clinical Characteristics, and Outcome of Nocardia Infection in Organ Transplant Recipients: A Matched Case-Control Study
2007 Standout
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
2008
Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation
2007 Standout
Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials
2005
Diabetes Mellitus Increases the Risk of Active Tuberculosis: A Systematic Review of 13 Observational Studies
2008 Standout
Nocardiosis following solid organ transplantation: a single-centre experience
2005
Antibody-Mediated Microcirculation Injury Is the Major Cause of Late Kidney Transplant Failure
2009
Mycophenolate Mofetil Decreases Acute Rejection and may Improve Graft Survival in Renal Transplant Recipients When Compared with Azathioprine: A Systematic Review
2009
Transplanted Infections: Donor-to-Host Transmission with the Allograft
1989
Mycobacterium tuberculosis infection following renal transplantation in Taiwan
2006
Infection in Solid-Organ Transplant Recipients
2007 Standout
Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and Nonadherence
2011 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
Infections in solid-organ transplant recipients
1997
Infectious Diseases Society of America Guidelines for the Diagnosis and Treatment of Asymptomatic Bacteriuria in Adults
2005 Standout
Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients
2013
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
2003 Standout
Does Reduction in Immunosuppression in Viremic Patients Prevent BK Virus Nephropathy in De Novo Renal Transplant Recipients? A Prospective Study
2008
Nocardiosis in Renal Transplant Patients
2007
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Meta-Analysis: The Efficacy of Strategies To Prevent Organ Disease by Cytomegalovirus in Solid Organ Transplant Recipients
2005
Aspergillus fumigatusand Aspergillosis
1999 Standout
Evolution and Clinical Pathologic Correlations of De Novo Donor-Specific HLA Antibody Post Kidney Transplant
2012 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Seasonal variation in blood pressure: Evidence, consensus and recommendations for clinical practice. Consensus statement by the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability
2020
2020 International Society of Hypertension Global Hypertension Practice Guidelines
2020 Standout
Recommendations for the Outpatient Surveillance of Renal Transplant Recipients
2000
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
2013
Works of G. Chong being referenced
Arterial hypertension in renal transplant recipients treated with tacrolimus or cyclosporine-neoral
2002
Lower Incidence of Chronic Allograft Nephropathy at 1 Year Post-Transplantation in Patients Treated with Mycophenolate Mofetil
2004
Seasonal modifications in blood pressure are mainly related to interdialytic body weight gain in dialysis patients
2004
LOW DOSE ANTITHYMOCYTE GLOBULINS IN RENAL TRANSPLANTATION
2000
Cinacalcet Chloride Is Efficient and Safe in Renal Transplant Recipients with Posttransplant Hyperparathyroidism
2006
[Nocardiosis--is it frequently observed after the introduction of new immunosuppressive agents in renal transplantation?].
2004
Transmission of <i>Mycobacterium tuberculosis</i> with Renal Allografts
1985
Prophylactic treatment of cytomegalovirus primary infection with ganciclovir in renal transplant recipients.
1995
Disappearance of anti-HLA antibodies in highly sensitized patients treated with erythropoietin.
1992